We are therefore committed to these fields, with the permanent aim of improving patient care.
We concentrate our therapeutic research efforts in fields where there is a high medical need, due to a lack of treatment and an increasing number of patients worldwide.
Treatment solutions are insufficient or even inexistent in non-alcoholic steatohepatitis (NASH), cholestatic liver diseases such as Primary Biliary Cirrhosis (PBC) or Primary Sclerosing Cholangitis (PSC), and chronic inflammatory bowel diseases.
GENFIT aims to address unmet medical needs by providing therapeutic and diagnostic solutions for these diseases. Most of our research and development efforts are thus dedicated to this quest.